{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-14T07:21:55.156572+00:00","published_at":"2026-10-14T04:47:14.667721+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:5:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"seat_on","from_id":"alpha:person:curtis-a-lockshin-ph-d","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Curtis A. Lockshin, Ph.D.","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2013-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:6:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"seat_on","from_id":"alpha:person:david-h-deming","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"David H. Deming","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:7:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"seat_on","from_id":"alpha:person:jonathan-e-freeman-ph-d","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Jonathan E. Freeman, Ph.D.","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"seat_on","from_id":"alpha:person:patricia-a-bradford","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Patricia A. Bradford","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"seat_on","from_id":"alpha:person:robert-l-ferrara","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Robert L. Ferrara","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"committee_of","from_id":"alpha:committee:phio-pharmaceuticals-corp:audit","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Audit","to_label":"Phio Pharmaceuticals Corp.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13","evidence_ids":["alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d"]},{"relationship_id":"alpha:relationship:chairs:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13:committee:phio-pharmaceuticals-corp:audit","relationship_type":"chairs","from_id":"alpha:person:robert-l-ferrara","to_id":"alpha:committee:phio-pharmaceuticals-corp:audit","from_label":"Robert L. Ferrara","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13","evidence_ids":["alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13:committee:phio-pharmaceuticals-corp:audit","relationship_type":"member_of","from_id":"alpha:person:patricia-a-bradford","to_id":"alpha:committee:phio-pharmaceuticals-corp:audit","from_label":"Patricia A. Bradford","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13","evidence_ids":["alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"committee_of","from_id":"alpha:committee:phio-pharmaceuticals-corp:audit-chair-compensation","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Audit · Chair; Compensation","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:member_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9:committee:phio-pharmaceuticals-corp:audit-chair-compensation","relationship_type":"member_of","from_id":"alpha:person:robert-l-ferrara","to_id":"alpha:committee:phio-pharmaceuticals-corp:audit-chair-compensation","from_label":"Robert L. Ferrara","to_label":"Audit · Chair; Compensation","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"committee_of","from_id":"alpha:committee:phio-pharmaceuticals-corp:audit-compensation-chair","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Audit; Compensation · Chair","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:member_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8:committee:phio-pharmaceuticals-corp:audit-compensation-chair","relationship_type":"member_of","from_id":"alpha:person:patricia-a-bradford","to_id":"alpha:committee:phio-pharmaceuticals-corp:audit-compensation-chair","from_label":"Patricia A. Bradford","to_label":"Audit; Compensation · Chair","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"committee_of","from_id":"alpha:committee:phio-pharmaceuticals-corp:compensation","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Compensation","to_label":"Phio Pharmaceuticals Corp.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16","evidence_ids":["alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d"]},{"relationship_id":"alpha:relationship:chairs:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16:committee:phio-pharmaceuticals-corp:compensation","relationship_type":"chairs","from_id":"alpha:person:patricia-a-bradford","to_id":"alpha:committee:phio-pharmaceuticals-corp:compensation","from_label":"Patricia A. Bradford","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16","evidence_ids":["alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16:committee:phio-pharmaceuticals-corp:compensation","relationship_type":"member_of","from_id":"alpha:person:robert-l-ferrara","to_id":"alpha:committee:phio-pharmaceuticals-corp:compensation","from_label":"Robert L. Ferrara","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16","evidence_ids":["alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:10:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"executive_of","from_id":"alpha:person:lisa-c-carson","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Lisa C. Carson","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2026-03-05","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:3b05fad10b6f6a3d5fb0c8a582be2f47fcbeac8f513e471cb9ef64fb95e56952"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:11:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"executive_of","from_id":"alpha:person:robert-j-bitterman","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Robert J. Bitterman","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2026-03-05","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:aae71f8700e0e950e751b612ad278fd0e7f8848c800a0409795219c04daf893b"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:12:company:25690616-6571-471a-9292-5baa843e70ef","relationship_type":"executive_of","from_id":"alpha:person:robert-m-infarinato","to_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","from_label":"Robert M. Infarinato","to_label":"Phio Pharmaceuticals Corp.","valid_from":"2026-03-05","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:89dd0d65aeca683bb65523e7cb0c86aa0776c94c8b51dd4410b8e5d0d34e79eb"]}]},"claims":[{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:5","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:curtis-a-lockshin-ph-d","object_label":"Curtis A. Lockshin, Ph.D.","object_source_name_forms":[],"value":"Curtis A. Lockshin, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:curtis-a-lockshin-ph-d","name":"Curtis A. Lockshin, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Phio Pharmaceuticals Corp. DEF 14A 2025-07-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":"2025-07-30","retrieved_at":"2026-04-28T22:56:01.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-30","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:6","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-h-deming","object_label":"David H. Deming","object_source_name_forms":[],"value":"David H. Deming: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-h-deming","name":"David H. Deming"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Phio Pharmaceuticals Corp. DEF 14A 2025-07-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":"2025-07-30","retrieved_at":"2026-04-28T22:56:01.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-30","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:7","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jonathan-e-freeman-ph-d","object_label":"Jonathan E. Freeman, Ph.D.","object_source_name_forms":[],"value":"Jonathan E. Freeman, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jonathan-e-freeman-ph-d","name":"Jonathan E. Freeman, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Phio Pharmaceuticals Corp. DEF 14A 2025-07-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":"2025-07-30","retrieved_at":"2026-04-28T22:56:01.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:8","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:patricia-a-bradford","object_label":"Patricia A. Bradford","object_source_name_forms":[],"value":"Patricia A. Bradford: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:patricia-a-bradford","name":"Patricia A. Bradford"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Phio Pharmaceuticals Corp. DEF 14A 2025-07-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":"2025-07-30","retrieved_at":"2026-04-28T22:56:01.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-30","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:9","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-l-ferrara","object_label":"Robert L. Ferrara","object_source_name_forms":[],"value":"Robert L. Ferrara: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-l-ferrara","name":"Robert L. Ferrara"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Phio Pharmaceuticals Corp. DEF 14A 2025-07-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":"2025-07-30","retrieved_at":"2026-04-28T22:56:01.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-30","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:10","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lisa-c-carson","object_label":"Lisa C. Carson","object_source_name_forms":[],"value":"Lisa C. Carson: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lisa-c-carson","name":"Lisa C. Carson"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:3b05fad10b6f6a3d5fb0c8a582be2f47fcbeac8f513e471cb9ef64fb95e56952","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PHIO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T06:53:24.346173+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:11","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:robert-j-bitterman","object_label":"Robert J. Bitterman","object_source_name_forms":[],"value":"Robert J. Bitterman: President, Chief Executive Officer and Chair of the Board of Directors","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:robert-j-bitterman","name":"Robert J. Bitterman"},"title":"President, Chief Executive Officer and Chair of the Board of Directors","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:aae71f8700e0e950e751b612ad278fd0e7f8848c800a0409795219c04daf893b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PHIO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T06:53:23.826304+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:leadership_role:12","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:robert-m-infarinato","object_label":"Robert M. Infarinato","object_source_name_forms":[],"value":"Robert M. Infarinato: Vice President and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:robert-m-infarinato","name":"Robert M. Infarinato"},"title":"Vice President and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-05","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:document:89dd0d65aeca683bb65523e7cb0c86aa0776c94c8b51dd4410b8e5d0d34e79eb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PHIO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T06:53:26.658773+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:13","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Robert L. Ferrara; Members Robert L. Ferrara (Chair); Patricia A. Bradford","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Robert L. Ferrara","members":[{"display_name":"Robert L. Ferrara","person_slug":"robert-l-ferrara","is_chair":true},{"display_name":"Patricia A. Bradford","person_slug":"patricia-a-bradford","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:25690616-6571-471a-9292-5baa843e70ef:committee_record:16","subject_id":"alpha:company:25690616-6571-471a-9292-5baa843e70ef","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Patricia A. Bradford; Members Patricia A. Bradford (Chair); Robert L. Ferrara","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Patricia A. Bradford","members":[{"display_name":"Patricia A. Bradford","person_slug":"patricia-a-bradford","is_chair":true},{"display_name":"Robert L. Ferrara","person_slug":"robert-l-ferrara","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-14T04:47:14.667721+00:00","sources":[{"id":"alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:ae185da55bbaf5becc41d1bb9bff3955f04fddc8ad18c594fd93617287c82824","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Phio Pharmaceuticals Corp. DEF 14A 2025-07-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":"2025-07-30","retrieved_at":"2026-04-28T22:56:01.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3b05fad10b6f6a3d5fb0c8a582be2f47fcbeac8f513e471cb9ef64fb95e56952","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PHIO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T06:53:24.346173+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:aae71f8700e0e950e751b612ad278fd0e7f8848c800a0409795219c04daf893b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PHIO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T06:53:23.826304+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:89dd0d65aeca683bb65523e7cb0c86aa0776c94c8b51dd4410b8e5d0d34e79eb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PHIO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000143774926007078/phio20251231_10k.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-16T06:53:26.658773+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:50ee04138efc971dc38608796b528f7ea4c333230e50e2360c7d990c3e7f643d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825005520/phio_idef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.837,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.856,"cross_source_agreement":0.75,"temporal_completeness":0.667},"diagnostics":{"published_claims":18,"factual_claims":18,"claims_with_linked_evidence":18,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-14T04:47:14.667721+00:00","observed_at":"2026-10-14T04:47:14.667721+00:00","reviewed_at":"2026-10-14T04:47:14.667721+00:00","verified_at":"2026-10-14T04:47:14.667721+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/phio-pharmaceuticals-corp/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/phio-pharmaceuticals-corp?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}